Are oligodendrocytes bystanders or drivers of Parkinson’s disease pathology?

Are oligodendrocytes bystanders or drivers of Parkinson’s disease pathology?

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	José María Salazar Campos, Lena F. Burbulla, Sarah Jäkel
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS Biology
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709285/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Are oligodendrocytes bystanders or drivers of Parkinson's disease pathology?
by: José María Salazar Campos, et al.
Published: (2025-01-01)

Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson’s disease
by: Maria Otero-Jimenez, et al.
Published: (2025-02-01)

Oligodendrocyte-astrocyte crosstalk in Parkinson’s disease mediates neuronal ferroptosis via the FGF signaling pathway
by: Sen Zhang, et al.
Published: (2025-05-01)

Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson’s Disease
by: Yibo Li, et al.
Published: (2025-07-01)

Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson’s disease via the prosaposin-GPR37-IL-6 axis
by: Qiang Ma, et al.
Published: (2025-02-01)

Bystander Choreography
by: Al Evangelista
Published: (2023-04-01)

Myelin oligodendrocyte glycoprotein associated disease
by: Nikhat Iqbal Tamboli, et al.
Published: (2025-04-01)

Predictors of Bystander Intervention: Examining the Heteronormative Bias in Bystander Intervention Research
by: Mellisa Holtzman
Published: (2024-02-01)

Bystanders’ Images of the Holocaust
by: Roma Sendyka
Published: (2020-01-01)

Oligodendrocyte Injury in Multiple Sclerosis.
by: Mateo Përgjegji, et al.
Published: (2025-01-01)

Exploring the early drivers of pain in Parkinson’s disease
by: Shiying Liu, et al.
Published: (2025-02-01)

Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players
by: Aurélien Chepy, et al.
Published: (2025-06-01)

Uric acid in atherosclerosis and cardiovascular diseases: innocent bystander or ruthless killer?
by: Giovanni Cimmino, et al.
Published: (2024-06-01)

Bioinformatics analysis reveals key mechanisms of oligodendrocytes and oligodendrocyte precursor cells regulation in spinal cord Injury
by: Xi Yue, et al.
Published: (2025-02-01)

Cor Triatriatum Dexter: An Innocent Bystander
by: Stephanie C. Fuentes Rojas, et al.
Published: (2022-04-01)

Mechanisms governing bystander activation of T cells
by: Mohammed Yosri, et al.
Published: (2024-11-01)

Traditional bullying and cyberbullying: Bystander strategies
by: V. L. Nazarov, et al.
Published: (2023-11-01)

Imaging alpha-synuclein pathology in Parkinson’s disease
by: Ruiqing Ni
Published: (2026-04-01)

Oligodendrocytes, the Forgotten Target of Gene Therapy
by: Yasemin Ozgür-Gunes, et al.
Published: (2024-11-01)

Out-of-Hospital Cardiac Arrest in Ireland 2012 to 2020: Bystander CPR, bystander defibrillation and survival in the Utstein comparator group
by: Tomás Barry, et al.
Published: (2025-01-01)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson’s Disease
by: Maria Graciela Cersosimo
Published: (2015-01-01)

To Intervene or Not to Intervene: An Experimental Methodology Measuring Actual Bystander Behaviour
by: Danielle Labhardt, et al.
Published: (2025-04-01)

Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases
by: Zhao Zhong Chong, et al.
Published: (2025-06-01)

Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model.
by: Jun-Yi Zhu, et al.
Published: (2013-01-01)

Label-free and fluorescence imaging of oligodendrocytes and myelin
by: Yasmine Kamen, et al.
Published: (2025-07-01)

Targeted ablation of oligodendrocytes triggers axonal damage.
by: Aniket Ghosh, et al.
Published: (2011-01-01)

Mutation of pescadillo disrupts oligodendrocyte formation in zebrafish.
by: Timothy Simmons, et al.
Published: (2012-01-01)

Oligodendrocyte Development in the Absence of Their Target Axons In Vivo.
by: Rafael Almeida, et al.
Published: (2016-01-01)

Challenges in the Diagnosis and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
by: Lekha Pandit
Published: (2025-01-01)

Rare Presentation of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease in Four Children
by: Vinothini Venkatachalam, et al.
Published: (2024-11-01)

An atypical cause of optic neuritis: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
by: Mark A. Colantonio, MD, et al.
Published: (2025-07-01)

Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease
by: Aurélien M. Badina, et al.
Published: (2025-07-01)

Closing the Gap: Addressing Racial Bias in Bystander CPR Administration
by: Ketan Tamirisa, et al.
Published: (2025-06-01)

Anomalous Right Coronary Artery: Culprit or Innocent Bystander?
by: Cooper B. Kersey, et al.
Published: (2025-01-01)

The Role of Bystander Cardiopulmonary Resuscitation: A Meta-Analysis
by: Xi Chen, et al.
Published: (2025-01-01)

Uric Acid in Primary Hyperparathyroidism: Marker, Consequence, or Bystander?
by: Matteo Malagrinò, et al.
Published: (2025-07-01)

Developing Bystander Intervention Skills in Bullying of Gifted Students
by: Seda Sevgili Koçak, et al.
Published: (2024-09-01)

Microbiome Dysbiosis as a Driver of Neurodegeneration: Insights into Alzheimer’s and Parkinson’s Diseases
by: Ana Jagodic, et al.
Published: (2025-04-01)

Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease
by: Asier Erramuzpe, et al.
Published: (2025-04-01)

Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis
by: Jacob M. Pfaffinger, et al.
Published: (2025-08-01)